Sun-oc, Teodora B.
HRN: 09-29-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2022
CEFTRIAXONE 1G (VIAL)
09/25/2022
10/01/2022
IVTT
2g
Q24
TNTC Pus Cells
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes